Beam Therapeutics Inc
BEAM
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.51B
Close$
$-25.93
173% downside
Current Fair Value
173% downsideOvervalued by 173% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.51 Billion |
|---|---|
| Enterprise Value | $3.37 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.81 |
| Beta | 2.2 |
| Outstanding Shares | 103,262,000 |
Return
| Return on Equity | -5.59% |
|---|---|
| Return on Assets | -4.39% |
| Return on Invested Capital | -5.79% |
Valuation & Multiples
| P/E Ratio | -53.34 |
|---|---|
| PEG | 389.84 |
| Price to Sales | 35.53 |
| Price to Book Ratio | 3.23 |
| Enterprise Value to Revenue | 25.51 |
| Enterprise Value to EBIT | -41.47 |
| Enterprise Value to Net Income | -52 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
$-1.02
Average shareholder expectationRevenue Estimate
$11.11 M
Average shareholder expectationNext Earnings Call
Expected Date
August 4, 2026
EPS Estimate
$-1.11
Average shareholder expectationRevenue Estimate
$14.53 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.5245▲ 43.97% |
|---|---|
| Total Calls | 581,500▼ 76.12% |
| Total Puts | 305,000▲ 47.63% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 109.44%▲ 5.26% |
|---|---|
| Total Invested | $2.58B▼ 12.98% |
| Investors Holding | 263▲ 6.00% |
ESG Score
No data